MedPath

Therapeutic effects of recombinant human soluble thrombomodulin in patients with DIC caused by severe burns:a historical control clinical trial.

Not Applicable
Conditions
DIC caused by severe burns
Registration Number
JPRN-UMIN000007965
Lead Sponsor
Yokohama City University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients aged < 15 years. (2)Patients showing intracranial, pulmonary or gastrointestinal hemo- rrhage. (3)Patients with a history of hypersensitivity to rhTM. (4)Pregnancy or possibly pregnancy. (5)Other patients judged to be inappropriate at the discretion of investigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath